cALD

FDA considers 'regulatory action' for bluebird's Skysona after blood cancer reports
Fierce Pharma
Mon, 12/2/24 - 07:46 pm
Bluebird Bio
Skysona
gene therapy
FDA
blood cancer
cALD
FDA probes blood cancer risk from bluebird's gene therapy, weighs regulatory action
Medpage Today
Wed, 11/27/24 - 09:59 pm
Bluebird Bio
Skysona
FDA
myelodysplastic syndrome
AML
cALD
New data underline cancer risk of Bluebird therapy for brain disease
BioPharma Dive
Thu, 10/10/24 - 11:15 am
Bluebird Bio
gene therapy
Skysona
cALD
Bluebird wins FDA approval of gene therapy for rare brain disorder
BioPharma Dive
Sun, 09/18/22 - 10:23 pm
Bluebird Bio
gene therapy
cALD
Skysona
FDA
FDA panel backs Bluebird gene therapy despite safety risks
BioPharma Dive
Fri, 06/10/22 - 10:56 am
Bluebird Bio
FDA
eli-cel
cALD
Blown off course, Bluebird shares tick up on positive gene therapy readout
Fierce Biotech
Mon, 03/15/21 - 10:54 am
Bluebird Bio
cALD
gene therapy
FDA
bluebird presents long-term data from CALD gene therapy
Pharmaforum
Fri, 09/20/19 - 09:28 am
Bluebird Bio
gene therapy
cALD
Lenti-D
Bluebird’s gene therapy halts progression of ‘devastating’ disease cALD
Fierce Biotech
Fri, 10/6/17 - 09:48 am
gene therapy
Bluebird Bio
cALD
Lenti-D